Question 63

The prescription appears to contain a look-alike/sound-alike error.

The pharmacy technician should alert the pharmacist because lamivudine is primarily used for the treatment of HIV and hepatitis B, not for seizures. This indicates a potential look-alike/sound-alike error, as the medication may have been confused with another drug that is indicated for seizure management.

A) the prescription appears to contain a look-alike/sound-alike error

This option is correct because lamivudine is not indicated for seizures. It is crucial for pharmacy technicians to recognize when a medication prescribed does not align with its approved uses, which in this case suggests a possible error in the prescription.

B) lamivudine requires special handling

This option is incorrect as lamivudine does not require special handling. While some medications may have specific storage or handling requirements, lamivudine is typically stored at room temperature and does not present unique handling challenges that would warrant alerting the pharmacist.

C) the prescription exceeds the maximum recommended daily dose

This option is incorrect because the prescribed dose of lamivudine at 100 mg once a day is within the recommended dosage guidelines for its intended uses. Therefore, this does not raise any concern regarding dosage errors.

D) lamivudine is subject to a REMS program

This option is also incorrect as lamivudine is not subject to a Risk Evaluation and Mitigation Strategy (REMS) program. REMS programs are typically associated with medications that have significant risks, which does not apply to lamivudine for the prescribed indication.

Conclusion

The correct answer indicates that the prescription likely contains a look-alike/sound-alike error, as lamivudine is not used for seizures. All other options are invalid in this context, as they do not pertain to the indication, dosage, or handling of lamivudine, highlighting the importance of verifying medication appropriateness in pharmacy practice.